Clinical Trials in Semarang, Indonesia
Locations / Semarang, Indonesia
Delta Trials lists 81 clinical trials conducted in Semarang, Indonesia, making it a notable site of clinical research activity. These trials addressing 110 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 3 trials in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Semarang research landscape.
81
Total Trials
110
Conditions
3
Terminated since 2020
Browse by condition (110 total)
- COVID-19 9 trialsAll COVID-19 trials
- Hypertension 3 trialsAll Hypertension trials
- Acute decompensated heart failure 2 trialsAll Acute decompensated heart failure trials
- Acute coronary syndrome 2 trialsAll Acute coronary syndrome trials
- Oxidative stress 2 trialsAll Oxidative stress trials
- St elevation myocardial infarction 2 trialsAll St elevation myocardial infarction trials
- All St-segment elevation myocardial infarction (stemi) trials
- Hypercholesterolemia 2 trialsAll Hypercholesterolemia trials
- Type 2 diabetes mellitus 2 trialsAll Type 2 diabetes mellitus trials
- Non-small cell lung cancer 2 trialsAll Non-small cell lung cancer trials
- Weight loss 2 trialsAll Weight loss trials
- Asthma 2 trialsAll Asthma trials
- Acute ischemic stroke 2 trialsAll Acute ischemic stroke trials
- Infectious disease 2 trialsAll Infectious disease trials
- Pregnancy 2 trialsAll Pregnancy trials
- Chronic kidney diseases 1 trialAll Chronic kidney diseases trials
- Kasai portoenterostomy 1 trialAll Kasai portoenterostomy trials
- Pneumonia 1 trialAll Pneumonia trials
- Insulin resistance 1 trialAll Insulin resistance trials
- Burnout, professional 1 trialAll Burnout, professional trials